Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team.

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

2.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team.

N Engl J Med. 2012 Jun 21;366(25):2345-57. doi: 10.1056/NEJMoa1114635. Epub 2012 May 21.

3.

Reduced lung-cancer mortality with low-dose computed tomographic screening.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD.

N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.

4.

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B, Crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.

JAMA. 2011 Jun 8;305(22):2295-303. doi: 10.1001/jama.2011.766.

PMID:
21642681
5.

The National Lung Screening Trial: overview and study design.

National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ.

Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808. Epub 2010 Nov 2.

6.

Selecting the right vendor: calibration services in a critical environment.

Hubler BE, Horvath KE.

Biomed Instrum Technol. 2007 Mar-Apr;41(2):113-6. Review. No abstract available.

PMID:
17432659
7.

Traumatic pulmonary arterial and venous pseudoaneurysms.

Hubler B, Earls JP, Stevens K.

AJR Am J Roentgenol. 1997 Nov;169(5):1354. No abstract available.

PMID:
9353457
8.

Age-related effects in rabbit hearts of N6-R-phenylisopropyladenosine, an adenosine A1 receptor agonist.

Mudumbi RV, Olson RD, Hubler BE, Montamat SC, Vestal RE.

J Gerontol A Biol Sci Med Sci. 1995 Nov;50(6):B351-7.

PMID:
7583791
9.

Determination of the gravitational constant with a lake experiment: New constraints for non-Newtonian gravity.

Hubler B, Cornaz A, Kündig W.

Phys Rev D Part Fields. 1995 Apr 15;51(8):4005-4016. No abstract available.

PMID:
10018875
10.

Determination of the gravitational constant at an effective interaction distance of 112 m.

Cornaz A, Hubler B, Kündig W.

Phys Rev Lett. 1994 Feb 21;72(8):1152-1155. No abstract available.

PMID:
10056636
11.

[Experience with the tranquilizer Valmane as additional therapy in vertebral disease].

Hübler B.

Z Allgemeinmed. 1969 Nov 30;45(33):1591-4. German. No abstract available.

PMID:
4247860

Supplemental Content

Loading ...
Support Center